Țară: Israel
Limbă: engleză
Sursă: Ministry of Health
LANSOPRAZOLE
TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
A02BC03
CAPSULES
LANSOPRAZOLE 15 MG
PER OS
Required
TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
LANSOPRAZOLE
LANSOPRAZOLE
For the treatment of duodenal ulcer, benign gastric ulcer, reflux oesophagitis and acid related disorders of the upper gastrointestinal tract. Healing, long term treatment and maintenance therapy for patients with gastro oesophageal reflux disease (GORD) or duodenal ulcer. Prevention of relapse in patients with GORD or duodenal ulcer. Eradication of H. Pylori from the upper gastrointestinal tract in patients with duodenal ulcer, gastritis or benign ulcer (in combination with appropriate antibiotics). Short term treatment (up to four weeks) of heartburn and/or upper epigastric pain associated with acid-related dyspepsia. Long-term management of pathological hypersecretory conditions including Zollinger Ellison syndrome.Treatment and prophylaxis of NSAID- associated benign gastric ulcers, duodenal ulcers and relief of symptoms in patients requiring continued NSAID treatment.
2010-07-31
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) – 1986 The medicine is dispensed with a doctor's prescription only LANSOPRAZOLE TEVA 30 MG Capsules COMPOSITION: Each capsule contains: Lansoprazole 30 mg For information regarding inactive ingredients and allergens, see section 2 - “Important information about some ingredients of the medicine” and section 6 - “Additional information”. READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. This leaflet contains concise information about the medicine. If you have additional questions, refer to the doctor or the pharmacist. This medicine has been prescribed for treatment of your illness. Do not pass it on to others. It may harm them even if it seems to you that their illness is similar. 1. WHAT IS THE MEDICINE INTENDED FOR? • Lansoprazole Teva inhibits the secretion of gastric acid and is therefore effective in treating acid-related disorders in the upper gastrointestinal tract. • For the treatment of gastric ulcer, duodenal ulcer, reflux oesophagitis, gastroesophageal reflux disease (GERD). • For prolonged and maintenance treatment to prevent recurrence of gastroesophageal reflux disease (GERD) or duodenal ulcer. • For combined treatment with antibiotics for the eradication of Helicobacter pylori (_H. pylori_), which is one of the main causes of peptic ulcer and gastritis. • For short-term treatment (up to 4 weeks) of dyspeptic effects caused by excessive gastric acidity, such as heartburn and/or upper abdominal pain. • For long-term treatment in hypersecretory conditions, including Zollinger-Ellison syndrome. • For the treatment and prophylaxis of peptic ulcer caused by treatment with non-steroidal anti-inflammatory drugs (NSAIDs), and for the relief of symptoms in patients receiving prolonged treatment with NSAIDs. THERAPEUTIC CLASS Proton pump inhibitors (PPI). 2. BEFORE USING THE MEDICINE: DO NOT USE THIS MEDICINE IF: • You are sensitive (allergic) to the active ingredient (Lansoprazole) or to any o Citiți documentul complet